GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,462.50p
   
  • Change Today:
      65.50p
  • 52 Week High: 1,671.00p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,079.10m
  • Volume: 11,473,020
  • Market Cap: £59,657m
  • RiskGrade: 129
  • Beta: 0.00

Latest ShareCast News

London close: Stocks mixed on robust US data, earnings flurry

By Josh White

Date: Wednesday 30 Jul 2025

(Sharecast News) - London equities ended Wednesday narrowly mixed as investors weighed stronger-than-expected US economic data against a wave of corporate earnings that failed to inspire.

GSK ShareCast News

GSK Q2 revenues grow, expects FY performance to ... 30-Jul-2025 ShareCast
London close: Stocks reverse gains to finish lower 28-Jul-2025 ShareCast
GSK and Hengrui unveil development deal worth up... 28-Jul-2025 ShareCast
London close: FTSE finishes week just shy of 9,000 18-Jul-2025 ShareCast
FDA rejects overall benefit/risk profile of GSK'... 18-Jul-2025 ShareCast

GSK Regulatory News

Transaction in Own Shares 30-Jul-2025 07:05 RNS
2nd Quarter Results 30-Jul-2025 07:00 RNS
Transaction in Own Shares 29-Jul-2025 07:00 RNS
GSK enters Hengrui Pharma collaboration agreements 28-Jul-2025 07:00 RNS
Transaction in Own Shares 28-Jul-2025 07:00 RNS

GSK Newspaper Links

GSK profits lifted by strong cancer drug sales 30-Jul-2025 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,462.50p
Change Today 65.50p
% Change 4.69 %
52 Week High 1,671.00p
52 Week Low 1,264.00p
Volume 11,473,020
Shares Issued 4,079.10m
Market Cap £59,657m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
19.28% below the market average19.28% below the market average19.28% below the market average19.28% below the market average19.28% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income Not Available
Growth
29.87% below the market average29.87% below the market average29.87% below the market average29.87% below the market average29.87% below the market average
54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 15
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 14-Aug-25 15-May-25
Paid 09-Oct-25 10-Jul-25
Amount 16.00p 16.00p

Trades for 30-Jul-2025

Time Volume / Share Price
17:45 7,700 @ 1,462.24p
15:59 5 @ 1,455.50p
16:16 1 @ 1,459.50p
15:52 5 @ 1,454.00p
15:52 4 @ 1,454.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page